13F Holdings
中文EN

A AGILENT TECHNOLOGIES, INC.

Laboratory Analytical Instruments · NYSE · SEC CIK 1090872 · Fiscal year ends 10/31

Financial factors as of 2026-07-31 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.6%
TTM net income YoY18.0%
TTM EPS YoY18.5%
Revenue 3-yr CAGR1.8%
Net income 3-yr CAGR8.3%

Margins

Gross margin53.8%
Operating margin22.2%
Net margin19.5%
FCF margin17.2%
EBITDA margin25.9%

Returns

ROE21.0%
ROA11.0%
ROIC (approx.)16.0%
Asset turnover0.56x

Leverage & solvency

Liabilities / assets47.3%
Debt / equity0.54x
Current ratio2.05x
Interest coverage15.46x

Cash quality & payout

Operating cash flow / net income1.12x
Accruals ratio-1.3%
Payout ratio19.9%
Capex / revenue4.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-10-31FY20242024-10-31FY20232023-10-31FY20222022-10-31FY20212021-10-31
Income statement
Revenue$6.95B$6.51B$6.83B$6.85B$6.32B
Cost of revenue$3.31B$2.98B$3.37B$3.13B$2.91B
Gross profit$3.64B$3.54B$3.46B$3.72B$3.41B
R&D expense$455.00M$479.00M$481.00M$467.00M$441.00M
SG&A expense$1.71B$1.57B$1.63B$1.64B$1.62B
Operating income$1.48B$1.49B$1.35B$1.62B$1.35B
Interest expense$112.00M$96.00M$95.00M$84.00M$81.00M
Pretax income$1.44B$1.52B$1.34B$1.50B$1.36B
Income tax$132.00M$232.00M$99.00M$250.00M$150.00M
Net income$1.30B$1.29B$1.24B$1.25B$1.21B
EBITDA$1.77B$1.75B$1.62B$1.94B$1.67B
EPS (basic)4.594.444.224.193.98
EPS (diluted)4.574.434.194.183.94
Dividends declared per share0.990.940.900.840.78
Weighted avg. shares (diluted)285.00M291.00M296.00M300.00M307.00M
Balance sheet
Cash & equivalents$1.79B$1.33B$1.59B$1.06B$1.49B
Receivables$1.49B$1.32B$1.29B$1.41B$1.17B
Inventory$1.02B$972.00M$1.03B$1.04B$830.00M
Current assets$4.59B$3.96B$4.19B$3.78B$3.80B
PP&E, net$2.02B$1.78B$1.27B$1.10B$945.00M
Goodwill$4.47B$4.48B$3.96B$3.95B$3.98B
Intangibles$445.00M$547.00M$475.00M$821.00M$981.00M
Total assets$12.73B$11.85B$10.76B$10.53B$10.71B
Current liabilities$2.35B$1.90B$1.60B$1.86B$1.71B
Short-term debt$304.00M$45.00M$0$36.00M$0
Long-term debt$3.05B$3.35B$2.73B$2.73B$2.73B
Total debt$3.35B$3.39B$2.73B$2.77B$2.73B
Total liabilities$5.99B$5.95B$4.92B$5.23B$5.32B
Shareholders' equity$6.74B$5.90B$5.84B$5.30B$5.39B
Net debt$1.56B$2.06B$1.15B$1.71B$1.24B
Shares outstanding283.05M285.19M292.12M295.26M302.00M
Cash flow statement
Operating cash flow$1.56B$1.75B$1.77B$1.31B$1.49B
Capital expenditure$407.00M$378.00M$298.00M$291.00M$188.00M
Free cash flow$1.15B$1.37B$1.47B$1.02B$1.30B
Investing cash flow-$394.00M-$1.26B-$310.00M-$338.00M-$749.00M
Financing cash flow-$715.00M-$752.00M-$930.00M-$1.37B-$696.00M
Depreciation & amortization$288.00M$257.00M$271.00M$317.00M$321.00M
Stock-based compensation$128.00M$129.00M$111.00M$125.00M$110.00M
Dividends paid$282.00M$274.00M$265.00M$250.00M$236.00M
Share buybacks$425.00M$1.15B$575.00M$1.14B$788.00M

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.